Analysis on vaccination of live attenuated varicella vaccine in children aged 1-12 in in Jinshan District, Shanghai
10.3969/j.issn.1006-2483.2020.05.014
- VernacularTitle:上海市金山区1-12岁儿童水痘减毒活疫苗接种情况分析
- Author:
Meng TIAN
1
;
Weiwei WANG
2
;
Hongcen YAO
1
;
JIngjing WANG
1
;
Jie ZHOU
1
Author Information
1. Shanghai Jinshan District Center for Disease Control and Prevention, Jinshan,Shanghai 201599, China
2. The Jinshan Branch of Shanghai Six People's Hospital, Jinshan,Shanghai 201599, China
- Publication Type:Journal Article
- Keywords:
Jinshan District;
Varicella vaccine;
Vaccination rate
- From:
Journal of Public Health and Preventive Medicine
2020;31(5):53-56
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the vaccination of live attenuated varicella vaccine ((VarV) in Jinshan District of Shanghai. Methods Descriptive and analytical epidemiological analysis was carried out using the information of VarV immunization of children born between November 1, 2006 and October 31, 2018 (1-12 years) in the Jinshan District Immunization Program Information System. Results There were 82 584 registered children aged 1-12 years in Jinshan District, and the vaccination rate of VarV at the first dose (VarV1) was 90.95%. The vaccination rate of children in this city was higher than that of migrant children, and the annual vaccination rate of children born in different years was between 59.81% and 99.93%. The vaccination rates in northern, central and southern Jinshan District were 89.25%, 93.27% and 91.39%, respectively. Among the 82 584 registered children, the second dose of VarV (VarV2) vaccination rate was 49.01%. The vaccination rate of children in this city was higher than that of migrant children, and the annual vaccination rate of children born in different years was between 25.94% and 77.14%. The vaccination rates in northern, central and southern Jinshan District were 28.72%, 45.88% and 66.30%, respectively. Conclusion The VarV1 vaccination rate of children aged 1-12 in Jinshan District was higher, but the VarV2 vaccination rate was relatively low. It is necessary to further strengthen publicity in key areas to improve the level of VarV2 vaccination.
